Headquartered at the University of Kansas Medical Center, the NIH-CTSAsupported Frontiers program, more formally called The Heartland Institute for Clinical and Translational Research, is a network of scientists from institutions in Kansas and the Kansas City region (www.FrontiersResearch.org). The Frontiers program is developing more efficient use and integration of biorepositories, genomic information and biomedical informatics which are important components for attaining the CTSA goals. Specific goals of Frontiers are to: 1) create a new academic home with innovative education and training programs for clinical and translational investigators that will transform the type, and increase the number of faculty and investigators needed to bring discoveries and research findings more rapidly to the point of care; 2) provide an enhanced coordinated translational research infrastructure that will speed the process from discovery to community research in Kansas and the Kansas City region; and 3) actively engage the community in developing, testing, and disseminating translational research through existing and new networks in Kansas and the Kansas City region.
The infrastructure needed (Frontiers goal #2) to speed the process of discovery, includes, in part, fundamental components such as bio-repository, genomics, and biomedical informatics. Each of these promotes and enhances discovery and each is foundational for moving discoveries from the bench to the bedside and becomes the foundation for this presentation. Each of these is described in order to provide an overview of how each is a component of translational research. 
Bio-repository
The bio-repository includes numerous components requiring integration of multiple sources of information flow with a goal of enhancing discovery to improve health. The bio-sample repository has several major functions including recruitment, sample acquisition, processing, storage, distribution and analysis. The repository also includes tissues, bodily fluids and cell lines. The process usually begins with recruitment and informed consent of the patient in order to collect bodily tissue and/or fluids (e.g., serum or plasma). Informed consent may occur during pre-admission testing, an outpatient visit or upon admission to the hospital. Sample collection may occur in the hospital, operating room and/or outpatient clinic. Samples are proactively acquired for future testing and may eventually be sent to multiple recipients. Information on personal and family histories, clinical intervention, and lifestyle factors is collected for each sample as well as: demographic, family history, medical history, epidemiologic risk factors, and clinical history. Annotated, high quality samples are collected and stored. Specific procedures are followed for the tissue banking scheme. For example, surgical specimens are collected by the pathologist with the aid of their physician assistant. Select tissue is identified for sampling and this information is entered into a database. A sample is then snap frozen and kept in liquid nitrogen or prepared for frozen sectioning. Samples frozen in liquid nitrogen may be stored and/or prepared for DNA and RNA extraction. Another sample of the same tissue is placed in fixative for sub-sequent histopathological analysis by storing in paraffin blocks for subsequent preparation of histological sections including routing staining, immunostaining, or tissue microarrays. Blood is separated into serum or plasma, red blood cells, leukocytes, DNA and stored at -80C. Blood samples are banked within 4 hours of draw after being barcoded. Sample quality is critical to the success of the bio-repository. Quality measures taken include compliance with best practices, qualification for membership in the International Society for Biological and Environmental Repositories, insisting on standard operating procedures, and certification by the College of American Pathologists (and others). NIH supported projects and others will/may require appropriate mechanisms for data sharing. Thus, patient consent, sample processing and inventory, questionnaire data, medical records and tumor registry data (when appropriate) must all be stored in databases, managed, and appropriate samples identified when requests are made for procurement. Biorepository management is complex with many components requiring oversight such as equipment, supplies, dedicated resources, liability, data management, standard policies and procedures, quality control, and compliance. Access to bio-samples is regulated by an advisory committee which considers requests from within and outside of the medical center.
Our goal is to enter genome and other types of 'omic' data such as metabolome, transcriptome and proteome into the system. Thus, sequencing data, genotype, methylation, expression, single nu- RR016475) . Bioinformatics studies and utilizes methods for storing, retrieving and analyzing biological data, such as DNA, RNA, proteins and their sequence as well as their structure, function, pathways and interactions. The overall mission of the core facility is to advance the understanding of integrative functions in biological systems, including human, through the application of computational models and data analysis with focus on Next Generation Sequencing Data Analysis and Microarray Data Analysis. The Bioinformatics core provides consulting, data analysis solutions and analysis of large-scale biological datasets produced by high-throughput genomics experiments. Thus, the core identifies opportunities and implements solutions for managing, visualizing, analyzing, and interpreting genomic data, including studies of gene expression (RNA-seq and microarrays), pathway analysis, protein-DNA binding (e.g. ChIP-seq), DNA methylation, and DNA variation, using high-throughput platforms in both human and model organisms.
A variety of services in bioinformatics and computational biology are provided by the Bioinformatics Core. 
